Details for New Drug Application (NDA): 207018
✉ Email this page to a colleague
The generic ingredient in IRBESARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; irbesartan. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; irbesartan profile page.
Summary for 207018
| Tradename: | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Applicant: | Unichem |
| Ingredient: | hydrochlorothiazide; irbesartan |
| Patents: | 0 |
Pharmacology for NDA: 207018
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
| Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 207018
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 207018 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-215 | 29300-215-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-215-10) |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 207018 | ANDA | Unichem Pharmaceuticals (USA), Inc. | 29300-215 | 29300-215-13 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-215-13) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG;150MG | ||||
| Approval Date: | Sep 19, 2017 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG;300MG | ||||
| Approval Date: | Sep 19, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
